1. Home
  2. OMH vs GDTC Comparison

OMH vs GDTC Comparison

Compare OMH & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ohmyhome Limited

OMH

Ohmyhome Limited

HOLD

Current Price

$1.78

Market Cap

17.6M

Sector

Finance

ML Signal

HOLD

Logo CytoMed Therapeutics Limited

GDTC

CytoMed Therapeutics Limited

HOLD

Current Price

$1.05

Market Cap

15.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OMH
GDTC
Founded
2015
2018
Country
Singapore
Singapore
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.6M
15.5M
IPO Year
2023
2023

Fundamental Metrics

Financial Performance
Metric
OMH
GDTC
Price
$1.78
$1.05
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.3M
38.4K
Earning Date
11-28-2025
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,264,748.00
$573,193.00
Revenue This Year
$28.40
$5.37
Revenue Next Year
$23.07
N/A
P/E Ratio
N/A
N/A
Revenue Growth
78.86
63.03
52 Week Low
$0.59
$0.89
52 Week High
$4.46
$3.68

Technical Indicators

Market Signals
Indicator
OMH
GDTC
Relative Strength Index (RSI) 87.78 26.33
Support Level $0.80 $0.89
Resistance Level $1.83 $1.39
Average True Range (ATR) 0.17 0.14
MACD 0.10 -0.03
Stochastic Oscillator 93.87 18.92

Price Performance

Historical Comparison
OMH
GDTC

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: